Chest
Volume 157, Issue 5, May 2020, Pages 1188-1198
Diffuse Lung Disease: Original ResearchDisease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry
Under a Creative Commons license
open access
Key Words
idiopathic pulmonary fibrosis
lung function
quality of life
Abbreviations
CASA-Q
Cough and Sputum Assessment Questionnaire
CPI
Composite Physiologic Index
Dlco
diffusing capacity for carbon monoxide
EQ-5D
European Quality of Life-5 Dimensions
GAP
Gender-Age-Lung Physiology
IPF
idiopathic pulmonary fibrosis
IPF-PRO
Idiopathic Pulmonary Fibrosis Prospective Outcomes
MCS
mental component score
QOL
quality of life
PCS
physical component score
SF-12
12-Item Short Form Health Survey
SGRQ
St. George’s Respiratory Questionnaire
VAS
visual analog scale
Cited by (0)
FUNDING/SUPPORT: The Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry is funded by Boehringer Ingelheim Pharmaceuticals, Inc. and coordinated by the Duke Clinical Research Institute.
© 2020 The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.